| |
| |
|
| Insider
Information: |
Ruegg Curtis |
| Relationship: |
EVP, Technical Operati... |
| City: |
Newark |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
23,944 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$75,663 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
23,944 |
|
|
| Total
Value |
$75,663 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Revance Therapeutics, Inc. |
RVNC |
EVP, Technical Operati... |
2016-06-13 |
23,944 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
57 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech OperationsOff |
• – – |
2014-02-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,606 |
|
- |
|
| RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
• – – |
2014-10-28 |
4 |
AS |
$20.00 |
$10,000 |
D/D |
(500) |
13,268 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
• – – |
2014-10-28 |
4 |
OE |
$2.55 |
$1,275 |
D/D |
500 |
13,768 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
• – – |
2014-12-09 |
4 |
AS |
$18.00 |
$9,000 |
D/D |
(500) |
14,106 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
• – – |
2014-12-09 |
4 |
OE |
$2.55 |
$1,275 |
D/D |
500 |
14,606 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
• – – |
2015-01-09 |
4 |
OE |
$2.55 |
$1,275 |
D/D |
500 |
14,606 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
• – – |
2015-01-09 |
4 |
AS |
$18.00 |
$9,000 |
D/D |
(500) |
14,106 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
EVP, Technical Operations |
• – – |
2015-03-09 |
4 |
OE |
$6.60 |
$3,300 |
D/D |
500 |
19,837 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
EVP, Technical Operations |
• – – |
2015-03-09 |
4 |
AS |
$18.00 |
$9,000 |
D/D |
(500) |
19,337 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
EVP, Technical Operations |
• – – |
2015-03-19 |
4 |
OE |
$6.60 |
$3,300 |
D/D |
500 |
19,837 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
EVP, Technical Operations |
• – – |
2015-03-19 |
4 |
AS |
$20.00 |
$10,000 |
D/D |
(500) |
19,337 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
EVP, Technical Operations |
• – – |
2015-05-15 |
4 |
AS |
$25.00 |
$12,500 |
D/D |
(500) |
19,337 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
EVP, Technical Operations |
• – – |
2015-05-15 |
4 |
OE |
$6.60 |
$3,300 |
D/D |
500 |
19,837 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
EVP, Technical Operations |
• – – |
2015-06-03 |
4 |
OE |
$6.60 |
$3,300 |
D/D |
500 |
18,527 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
EVP, Technical Operations |
• – – |
2015-06-03 |
4 |
AS |
$30.00 |
$15,000 |
D/D |
(500) |
18,027 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
EVP, Technical Operations |
• – – |
2016-01-28 |
4 |
D |
$20.30 |
$15,489 |
D/D |
(763) |
17,264 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
• – – |
2014-11-18 |
4 |
OE |
$2.55 |
$2,550 |
D/D |
1,000 |
15,106 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
• – – |
2014-11-18 |
4 |
AS |
$16.00 |
$16,000 |
D/D |
(1,000) |
14,106 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
• – – |
2014-12-17 |
4 |
AS |
$16.45 |
$16,450 |
D/D |
(1,000) |
14,106 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
• – – |
2014-12-17 |
4 |
OE |
$2.55 |
$2,550 |
D/D |
1,000 |
15,106 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
• – – |
2015-01-20 |
4 |
OE |
$2.55 |
$2,550 |
D/D |
1,000 |
15,106 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
• – – |
2015-01-20 |
4 |
AS |
$17.25 |
$17,250 |
D/D |
(1,000) |
14,106 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
EVP, Technical Operations |
• – – |
2015-02-17 |
4 |
OE |
$2.55 |
$5,912 |
D/D |
1,000 |
20,337 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
EVP, Technical Operations |
• – – |
2015-02-17 |
4 |
AS |
$16.80 |
$16,800 |
D/D |
(1,000) |
19,337 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
EVP, Technical Operations |
• – – |
2016-02-08 |
4 |
OE |
$8.70 |
$8,700 |
D/D |
1,000 |
18,264 |
0 |
- |
|
57 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
